Merrimack Pharmaceuticals Inc (MACK): Merrimack Pharmaceuticals' CEO …

Published August 31, 2013

Merrimack Pharmaceuticals Inc (MACK): Merrimack Pharmaceuticals' CEO …
First we have built the fully integrated cancer focused biotech company operating at scale. We have six novel … We were excited with the potential of 398 to address the big need for better therapies in the second line treatment of pancreatic cancer … Read more on Seeking Alpha

DaVita HealthCare Partners Inc (DVA): DaVita HealthCare Partners …
Second, however, we are very, very disappointed that the small changes to the proposed ESCO design will not make it one that merits significant investment; and to implement the kind of spectacular success that we've had in integrated care, the proven … Read more on Seeking Alpha